Tag Archives: Eisai

FDA Approves Halaven for Late-Stage Breast Cancer

Good news for patients with late stage metastatic breast cancer.  The US Food and Drug Administration (FDA) approved eribulin mesylate injection (Halaven; Eisai, Inc) for the treatment of metastatic breast cancer in patients who have received at least 2 prior … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , , , , , , , | Comments Off on FDA Approves Halaven for Late-Stage Breast Cancer